The ability of both strains to convert p-HPA to p-cresol in BHI, yet the inability to convert tyrosine via p-HPA to p-cresol indicates that constituents in the rich media may inhibit the conversion of tyrosine to p-cresol. Figure 2 Detection and production of p -cresol by 630Δ erm and R20291 using NMR spectroscopy and zNose™ gas chromatography. The relative production of p-cresol in rich media (BHI) supplemented with 0.1% p-HPA for strains 630Δerm and R20291 by A) NMR spectroscopy and B) zNose™ gas chromatography. The p-cresol peak URMC-099 molecular weight is indicated
with an arrow, at 6.7 seconds for zNose™ experiments Construction of gene inactivation mutants in C. difficile Three co-located genes (hpdB, hpdC and hpdA) are thought to encode the decarboxylase that converts p-HPA to p-cresol in strains 630Δerm and R20291. Gene inactivation mutants were constructed using the ClosTron method [17] in strains 630Δerm (mutants 630ΔermΔhpdB and 630ΔermΔhpdC) and strain R20291 (mutants R20291ΔhpdA and R20291ΔhpdC). The group II intron from the ClosTron system check details was retargeted using the Sigma TargeTron algorithm to insert into hpdA, hpdB and hpdC in the sense orientation for hpdA and hpdC at position 254 bp and 174 bp, respectively (from the
start of the ORF), and in the antisense orientation for hpdB at 748 bp (Figure 3A). Verification of successful mutant construction was performed using three independent PCR screens (Figure 3B). The RAM specific PCR confirmed the loss of the group I intron interrupting the ermB RAM, indicating chromosomal integration of the intron. The gene specific and the intron specific primer revealed insertion of the RAM into the target gene, and the gene specific primers flanking the insertion site revealed an increase in 1.9 kb in size for the mutants compared to the wild-type (Figure 3B). The insertion site was verified by
sequencing and by Southern blot analysis of the mutants using the Terminal deoxynucleotidyl transferase intron specific probe which confirmed insertion of a single site-specific group II intron for all the hpdBCA operon mutants tested (Figure 3C). Figure 3 The hpdBCA operon and verification of mutant construction. The hpdBCA operon with insertion sites for the targeted ClosTron selleck chemicals mutagenesis, the number refers to the insertion site (bp) and the s/a refers to sense/antisense orientation of the ClosTron insert. B) PCR screen of the mutants (M = mutant; W = wild type; P = plasmid and “”-”" negative control). Three PCR screens were performed, gene specific forward and reverse primers, intron specific with gene specific primers, and RAM specific primers (Heap et al., 2007). C) Southern blot using a probe specific to the inserted intron. HindIII digests were performed on DNA from M = mutant; W = wild type; P = plasmid. The strains and primer sets are indicated on each figure and in tables 1 and 2.
Related posts:
- , 2008) Translocation of CagA and by which induced IL-8 producti
- The 18 clinical isolates
and the two type strains (B meg - There was no obvious different in the growth rate of strains SC-1
- Both alleles were cloned into the R6K-origin
based suicid - The ΔΔCT method was used to calculate the relative expression of